Compare OPRX & DLHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | OPRX | DLHC |
|---|---|---|
| Founded | 2006 | 1969 |
| Country | United States | United States |
| Employees | N/A | 2300 |
| Industry | Business Services | Business Services |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 117.1M | 75.7M |
| IPO Year | 2008 | 2012 |
| Metric | OPRX | DLHC |
|---|---|---|
| Price | $7.79 | $3.76 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $16.67 | N/A |
| AVG Volume (30 Days) | ★ 141.3K | 10.1K |
| Earning Date | 05-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 124.55 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $109,429,000.00 | $41,923,000.00 |
| Revenue This Year | $3.88 | N/A |
| Revenue Next Year | $8.34 | $0.05 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 18.78 | 2.57 |
| 52 Week Low | $4.54 | $3.79 |
| 52 Week High | $22.25 | $8.09 |
| Indicator | OPRX | DLHC |
|---|---|---|
| Relative Strength Index (RSI) | 49.61 | 27.67 |
| Support Level | $5.78 | N/A |
| Resistance Level | $8.30 | $5.55 |
| Average True Range (ATR) | 0.37 | 0.14 |
| MACD | -0.13 | -0.02 |
| Stochastic Oscillator | 40.94 | 14.65 |
OptimizeRx Corp is engaged in the healthcare market in the United States. is a digital healthcare technology company that connects over two million HCPs and millions of their patients through an intelligent technology platform embedded within a proprietary omnichannel network. OptimizeRx helps life sciences organizations engage and support their customers through its combined HCP and DTC marketing strategies.
DLH Holdings Corp delivers health and readiness solutions for federal government customers through digital transformation and cyber security, science research and development, and systems engineering and integration. It provides technology-enabled business process, program management, and digital transformation solutions to U.S. government agencies, focusing on large-scale, technology-powered health and defense initiatives for agencies including HHS, VA, DoD, and their sub-agencies. Its revenues come from technology-enabled business process outsourcing, program management solutions, and public health research and analytics under time-and-materials, cost-reimbursable, and firm-fixed-price contracts.